Bone Marrow TransplantationHematopoietic Stem Cell TransplantationPeripheral Blood Stem Cell TransplantationTransplantation, AutologousTransplantation, HomologousStem Cell TransplantationBone Marrow CellsBone MarrowStem CellsHematopoietic Stem Cell MobilizationHematopoietic Stem CellsGraft vs Host DiseaseTransplantation ConditioningGranulocyte Colony-Stimulating FactorHematologic NeoplasmsGraft SurvivalLeukapheresisTransplantation ChimeraWhole-Body IrradiationAntigens, CD34BusulfanTissue DonorsCombined Modality TherapyCyclophosphamideTreatment OutcomeBlood Component RemovalMelphalanHematopoiesisLeukemiaLiver TransplantationCord Blood Stem Cell TransplantationHistocompatibility TestingHistocompatibilityRecurrenceMultiple MyelomaAnemia, AplasticCell DifferentiationAntineoplastic Combined Chemotherapy ProtocolsBone Marrow PurgingRemission InductionMesenchymal Stem Cell TransplantationLymphoma, Non-HodgkinTime FactorsTransplantation, IsogeneicMyeloablative AgonistsImmunosuppressive AgentsBone Marrow DiseasesAdult Stem CellsColony-Forming Units AssayLeukemia, Myeloid, AcuteRetrospective StudiesBlood CellsEtoposideMice, Inbred C57BLKidney TransplantationFlow CytometryLeukemia, Myelogenous, Chronic, BCR-ABL PositiveCells, CulturedDisease-Free SurvivalBlood Cell CountSurvival AnalysisBone and BonesEmbryonic Stem CellsCell SeparationSurvival RateTransplantation ImmunologyT-LymphocytesLymphocyte DepletionCytarabineMyelodysplastic SyndromesPrecursor Cell Lymphoblastic Leukemia-LymphomaHematologic DiseasesGraft vs Leukemia EffectThiotepaAntineoplastic Agents, AlkylatingRadiation ChimeraSalvage TherapyMesenchymal Stromal CellsVidarabineImmunosuppressionInfectionHLA AntigensAcute DiseaseCarmustineHodgkin DiseaseCell LineageLymphocyte TransfusionCell TransplantationCytomegalovirus InfectionsLeukocyte TransfusionFollow-Up StudiesGraft vs Tumor EffectLeukemia, MyeloidHepatic Veno-Occlusive DiseaseGraft RejectionCyclosporineLymphomaAntigens, CDLeukocyte CountImmunophenotyping